Capricor Therapeutics Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues to Invest in RD FUBO Q1 2026 Earnings Narrower Loss Drives Significant EPS Beat ASMB Q1 2026 Earnings Narrowed Loss and Pipeline Progress Boost Investor Sentiment TECX Q1 2026 Earnings Loss Widens but Pipeline Optimism Drives Stock Higher MGNX Q1 2026 Earnings Narrowed Loss Meets Street Views Amid Pipeline Progress WCN Q1 2026 Earnings Waste Connections Beats EPS Estimates Amid Quiet Market Reaction